BRPI1009422A2 - biomateriais injetáveis - Google Patents

biomateriais injetáveis

Info

Publication number
BRPI1009422A2
BRPI1009422A2 BRPI1009422A BRPI1009422A BRPI1009422A2 BR PI1009422 A2 BRPI1009422 A2 BR PI1009422A2 BR PI1009422 A BRPI1009422 A BR PI1009422A BR PI1009422 A BRPI1009422 A BR PI1009422A BR PI1009422 A2 BRPI1009422 A2 BR PI1009422A2
Authority
BR
Brazil
Prior art keywords
injectable biomaterials
biomaterials
injectable
Prior art date
Application number
BRPI1009422A
Other languages
English (en)
Inventor
Anthony Steven Weiss
Suzanne Marie Mithieux
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901028A external-priority patent/AU2009901028A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Publication of BRPI1009422A2 publication Critical patent/BRPI1009422A2/pt
Publication of BRPI1009422B1 publication Critical patent/BRPI1009422B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
BRPI1009422-9A 2009-03-10 2010-03-10 Biomateriais injetáveis BRPI1009422B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2009901028A AU2009901028A0 (en) 2009-03-10 Injectable biomaterials
AU2009901028 2009-03-10
PCT/AU2010/000275 WO2010102337A1 (en) 2009-03-10 2010-03-10 Injectable biomaterials

Publications (2)

Publication Number Publication Date
BRPI1009422A2 true BRPI1009422A2 (pt) 2016-03-01
BRPI1009422B1 BRPI1009422B1 (pt) 2019-10-01

Family

ID=42727703

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009422-9A BRPI1009422B1 (pt) 2009-03-10 2010-03-10 Biomateriais injetáveis

Country Status (13)

Country Link
US (1) US8974803B2 (pt)
EP (3) EP3566713B1 (pt)
JP (1) JP5684154B2 (pt)
KR (1) KR101708622B1 (pt)
CN (1) CN102348464B (pt)
AU (1) AU2010223851B2 (pt)
BR (1) BRPI1009422B1 (pt)
CA (1) CA2787849C (pt)
DK (2) DK3566713T3 (pt)
ES (2) ES2871977T3 (pt)
HU (2) HUE053947T2 (pt)
PL (1) PL3566713T3 (pt)
WO (1) WO2010102337A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365746A (ja) * 1989-08-04 1991-03-20 Nec Corp 入出力制御装置
CN102348464B (zh) 2009-03-10 2016-05-25 悉尼大学 可注射生物材料
SG177615A1 (en) * 2009-07-10 2012-03-29 Dow Global Technologies Llc Core/shell rubbers for use in electrical laminate compositions
DK2760466T3 (da) * 2011-09-30 2019-06-17 Allergan Pharmaceuticals Int Ltd In-vivo-syntese af elastisk fiber
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
CN105246520B (zh) 2012-12-10 2017-11-21 埃拉斯塔根私人有限公司 可缩放的三维弹性构建体制造
BR112016003082A8 (pt) * 2013-08-13 2020-01-28 Elastagen Pty Ltd uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida
ITMI20131927A1 (it) 2013-11-20 2015-05-21 Cosmo Technologies Ltd Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection. emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica
DE102015207843B4 (de) 2015-04-28 2018-06-07 Duesenfeld Gmbh Verfahren zum Behandeln gebrauchter Batterien und Batterie-Verarbeitungsanlage
AU2016314775A1 (en) 2015-09-01 2018-03-22 Allergan Pharmaceuticals International Limited Formation of bone
US10899667B2 (en) * 2017-05-26 2021-01-26 Clemson University Covalently cross-linked lignocellulosic composites and applications thereof
CN107376024B (zh) * 2017-06-29 2021-03-16 成都清科生物科技有限公司 一种用于治疗女性压力性尿失禁的注射制剂及注射方法
BR112022003367A2 (pt) * 2019-08-23 2022-05-17 Allergan Pharmaceuticals Int Ltd Tropoelastina para uso em tratamento de cicatrizes de acne

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232458B1 (en) 1992-12-22 2001-05-15 The University Of Sydney Synthetic polynucleotides encoding tropoelastin
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
CA2262446A1 (en) 1996-08-07 1998-02-12 Protein Specialties, Ltd. Self-aligning peptides derived from elastin and other fibrous proteins
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7193043B1 (en) 1998-07-17 2007-03-20 Weiss Anthony S Tropoelastin derivatives
CA2383539C (en) 1999-05-28 2007-12-04 Kenton W. Gregory Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
WO2001036000A1 (en) 1999-11-15 2001-05-25 Bio Syntech Canada, Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
US20050244393A1 (en) * 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
WO2002096978A1 (fr) 2001-05-30 2002-12-05 Keiichi Miyamoto Elastine reticulee et son procede de production
US7641643B2 (en) * 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
US8226715B2 (en) * 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
WO2007048115A2 (en) 2005-10-19 2007-04-26 Gregory Kenton W Method of using and producing tropoelastin and tropoelastin biomaterials
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
US8101717B2 (en) 2006-11-13 2012-01-24 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
CN102348464B (zh) 2009-03-10 2016-05-25 悉尼大学 可注射生物材料
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof

Also Published As

Publication number Publication date
JP2012519713A (ja) 2012-08-30
KR101708622B1 (ko) 2017-02-21
CA2787849A1 (en) 2010-09-16
DK2405936T3 (da) 2019-11-04
BRPI1009422B1 (pt) 2019-10-01
ES2755902T3 (es) 2020-04-24
HUE053947T2 (hu) 2021-08-30
PL3566713T3 (pl) 2021-12-06
AU2010223851B2 (en) 2017-03-16
JP5684154B2 (ja) 2015-03-11
HUE047235T2 (hu) 2020-04-28
AU2010223851A1 (en) 2011-09-22
EP2405936B1 (en) 2019-08-21
ES2871977T3 (es) 2021-11-02
CA2787849C (en) 2018-03-06
US8974803B2 (en) 2015-03-10
KR20110127746A (ko) 2011-11-25
CN102348464A (zh) 2012-02-08
DK3566713T3 (da) 2021-04-06
EP3566713B1 (en) 2021-03-03
EP3566713A1 (en) 2019-11-13
CN102348464B (zh) 2016-05-25
EP2405936A4 (en) 2012-12-19
EP3881825A1 (en) 2021-09-22
US20120003283A1 (en) 2012-01-05
WO2010102337A1 (en) 2010-09-16
EP2405936A1 (en) 2012-01-18

Similar Documents

Publication Publication Date Title
DK2405936T3 (da) Injicerbare biomaterialer
DK2414015T3 (da) Laryngoskopsystem
DE112010004215A5 (de) Hydrostataktor
BRPI1008774A2 (pt) espiroamida substituída
DK2411442T4 (da) Umættet polyesterresin
BRPI1008827A2 (pt) deisobutenizador
DK2430035T3 (da) Uracylspipooxetannukleosider
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
DE112009005323A5 (de) Hebelarmprüfmaschine
DE112010004249A5 (de) Spindelaktor
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
BRPI1008070A2 (pt) tricianoboratos
UY33111A (es) Jeringas
DK2483126T3 (da) Skinnekøretøj
DE112010004865T8 (de) Lamellennassreibkupplung
DK2506968T3 (da) Faujasit-zeolit
DE112010003255A5 (de) Fördergutverteiler
BRPI1010159A2 (pt) bistuti
DE602010000025D1 (de) Fahrzeugsitzgurtvorrichtung
BR112012006693A2 (pt) combinação
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas
DE112010002351A5 (de) Klemmorrichtung
BR112012006968A2 (pt) combinação

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ELASTAGEN PTY LTD (AU)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/03/2010, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/03/2010, OBSERVADAS AS CONDICOES LEGAIS

B25A Requested transfer of rights approved

Owner name: ALLERGAN AUSTRALIA PTY LTD (AU)

B25A Requested transfer of rights approved

Owner name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE)